128 related articles for article (PubMed ID: 13583888)
1. Phenaglycodol therapy in cerebral palsy.
KUGELMASS IN
Ann N Y Acad Sci; 1958 Oct; 72(8):271-92. PubMed ID: 13583888
[No Abstract] [Full Text] [Related]
2. Phenaglycodol: a new antiepileptic agent.
GRUBER CM; MOSIER JM
Proc Soc Exp Biol Med; 1957 Feb; 94(2):384-5. PubMed ID: 13408268
[No Abstract] [Full Text] [Related]
3. A comparison of phenaglycodol (ultran), meprobamate and a placebo in abstinent alcoholics.
SMITH JA; RUTHERFORD A; FANNING R
Am J Psychiatry; 1957 Oct; 114(4):364-5. PubMed ID: 13458502
[No Abstract] [Full Text] [Related]
4. Comparative effect of phenaglycodol, meprobamate, and a placebo on the irritable colon; a double-blind study.
KASICH AM; FEIN HD; MILLER JW
Am J Dig Dis; 1959 Mar; 4(3):229-34. PubMed ID: 13626924
[No Abstract] [Full Text] [Related]
5. [Positive effect of phenaglycodol on characterologic disorders in epileptic patients].
Szemraj J; Janusz A; Lenartowska K
Neurol Neurochir Pol; 1968; 2(3):445-7. PubMed ID: 4880821
[No Abstract] [Full Text] [Related]
6. [Early results of the use of 2-p-chlorophenyl-3-methyl-2,3-butanediol (phenaglycodol) in neuropsychiatric therapy].
IMBERCIADORI E
Minerva Med; 1960 Mar; 51():757-60. PubMed ID: 13852743
[No Abstract] [Full Text] [Related]
7. [Identification and urinary elimination of phenaglycodol].
CIMA L; FASSINA G
Farmaco Prat; 1959 Jul; 14():416-23. PubMed ID: 13849393
[No Abstract] [Full Text] [Related]
8. Placebo-controlled evaluation of phenaglycodol in anxious, depressed outpatients.
Brauzer B; Goldstein BJ
J Clin Pharmacol New Drugs; 1972 Jul; 12(7):280-5. PubMed ID: 4557536
[No Abstract] [Full Text] [Related]
9. Mode of action of phenaglycodol, a new neurosedative agent.
JONES GT; SLATER IH; YOUNG WK
Proc Soc Exp Biol Med; 1956 Dec; 93(3):528-31. PubMed ID: 13389510
[No Abstract] [Full Text] [Related]
10. Comparative effects of phenaglycodol and meprobamate on anxiety reactions.
ZUKIN P; ARNOLD DG; KESSLER CR
J Nerv Ment Dis; 1959 Aug; 129():193-5. PubMed ID: 13847900
[No Abstract] [Full Text] [Related]
11. Tolerance and withdrawal hyperexcitability induced in mice by chronic administration of phenaglycodol.
CHIN L; SWINYARD EA
Proc Soc Exp Biol Med; 1958 Jan; 97(1):251-4. PubMed ID: 13518240
[No Abstract] [Full Text] [Related]
12. An analysis of the analgesic effect of dextropro-poxyphene hydrochloride, phenaglycodol, and aspirin combination (darvo-tran).
SETTEL E
Antibiotic Med Clin Ther (New York); 1959 Sep; 6():512-7. PubMed ID: 14445201
[No Abstract] [Full Text] [Related]
13. Primidone and chlordiazepoxide in cerebral palsy.
THORN I
Dev Med Child Neurol; 1962 Jun; 4():325-7. PubMed ID: 13921015
[No Abstract] [Full Text] [Related]
14. Clinical experiences with chlordiazepoxide (librium) in infantile cerebral palsy.
KEATS S; KAMBIN P; NORDLUND T
Dev Med Child Neurol; 1962 Jun; 4():336-7. PubMed ID: 14454732
[No Abstract] [Full Text] [Related]
15. Use of a new relaxant drug in cerebral palsy. (A preliminary report).
KEATS S; KAMBIN P; NORLUND T
Dis Nerv Syst; 1962 Jul; 23():399-403. PubMed ID: 14454733
[No Abstract] [Full Text] [Related]
16. Pentylenetetrazol seizure threshold in meprobamate- and phenaglycodol-treated mice.
CHIN L; SWINYARD EA
J Am Pharm Assoc Am Pharm Assoc; 1959 Jan; 48(1):6-8. PubMed ID: 13610718
[No Abstract] [Full Text] [Related]
17. Librium.
DEBERDT R
Dev Med Child Neurol; 1962 Aug; 4():445. PubMed ID: 13884644
[No Abstract] [Full Text] [Related]
18. Determination of phenaglycodol in biologic specimens by ultraviolet spectrophotometry.
Wallace JE
J Pharm Sci; 1968 Mar; 57(3):426-9. PubMed ID: 5655580
[No Abstract] [Full Text] [Related]
19. Mechanism and management of cerebral palsy.
KUGELMASS IN
Int Rec Med Gen Pract Clin; 1958 Apr; 171(4):186-207. PubMed ID: 13525008
[No Abstract] [Full Text] [Related]
20. [Experience with the drug neuroton in the treatment of cerebral palsy].
Kühn R
Beitr Orthop Traumatol; 1968; 15(7):422-8. PubMed ID: 5728410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
